The following MPN videos provide information from leading MPN experts. The first series of videos were recorded at the 10th International Patient Symposium on Myeloproliferative Neoplasms (MPNs), October 23, 2019 in NYC. Thanks to Cancer Research & Treatment Fund (CR&T) for providing these educational videos. Videos ©CR&T. Stay tuned as more educational videos will be added during 2020.
Polycythemia Vera and Myelofibrosis Patients Should Be Treated Early with Interferon – RT Silver, MD
Richard T. Silver, MD (Weill Cornell Medicine, New York City) discusses why patients with polycythemia vera and myelofibrosis should be treated with interferon early rather than late.
Immunotherapy – Hans Hasselbalch, MD
Hans Hasselbalch, MD, PhD (Roskilde Hospital, University of Copenhagen, Denmark) discusses the latest developments in immunotherapy for myeloproliferative neoplasms (MPNs).
New MPN Treatments and Drugs – Srdan Verstovsek, MD, PhD
Srdan Verstovsek, MD, PhD (University of Texas MD Anderson Cancer Center, Houston) discusses new MPN treatments and drugs.
Current Management of Myelofibrosis – Ronald Hoffman, MD
Ronald Hoffman, MD (Icahn School of Medicine at Mount Sinai, New York, NY) discusses the current management of myelofibrosis.
Essential Thrombocythemia: A Case Study – Jerry L. Spivak, MD
Jerry L. Spivak, MD (Johns Hopkins University School of Medicine, Baltimore) discusses essential thrombocythemia.
Current State of Stem Cell Transplants in MPN Therapy – Koen van Besien, MD
Koen van Besien, MD (Weill Cornell Medicine, New York, NY) discusses the current state of stem cell transplants in MPN therapy.
MPN Research Presented at the 2018 American Society of Hematology Annual Meeting – A.I. Schafer, MD
Andrew I. Schafer, MD (Weill Cornell Medicine, New York City) summarizes MPN research presented at the 2018 American Society of Hematology (ASH) Annual Meeting.
Diet, Exercise, and Mindfulness – Robyn Scherber, MD, MPH
Robyn Scherber, MD, MPH (UT Health San Antonio MD Anderson Cancer Center) discusses diet, exercise, and mindfulness for people living with myeloproliferative neoplasms (MPNs).